VERACYTE, INC. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Veracyte, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • Veracyte, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $4.61M.
  • Veracyte, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$67.3M, a 100% decline year-over-year.
  • Veracyte, Inc. annual Operating Income (Loss) for 2023 was -$85.8M, a 109% decline from 2022.
  • Veracyte, Inc. annual Operating Income (Loss) for 2022 was -$41.1M, a 49.8% increase from 2021.
  • Veracyte, Inc. annual Operating Income (Loss) for 2021 was -$81.9M, a 131% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$85.8M -$44.7M -109% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$41.1M +$40.8M +49.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$81.9M -$46.5M -131% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$35.4M -$20.3M -134% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$15.1M +$7.11M +32% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$22.2M +$4.31M +16.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-22
2017 -$26.5M +$2.27M +7.86% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 -$28.8M +$4.66M +13.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-25
2015 -$33.5M -$4.46M -15.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 -$29M -$5.83M -25.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$23.2M -$4.24M -22.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 -$18.9M -$3.66M -24% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-25
2011 -$15.3M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.